tradingkey.logo

Rapid Micro Biosystems Inc

RPID

3.370USD

+0.150+4.66%
終値 09/19, 16:00ET15分遅れの株価
148.48M時価総額
損失額直近12ヶ月PER

Rapid Micro Biosystems Inc

3.370

+0.150+4.66%
詳細情報 Rapid Micro Biosystems Inc 企業名
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission critical automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company's flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control, testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
企業情報
企業コードRPID
会社名Rapid Micro Biosystems Inc
上場日Jul 15, 2021
最高経営責任者「CEO」Mr. Robert (Rob) Spignesi
従業員数163
証券種類Ordinary Share
決算期末Jul 15
本社所在地25 Hartwell Avenue
都市LEXINGTON
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号02421
電話番号19783493200
ウェブサイトhttps://www.rapidmicrobio.com/
企業コードRPID
上場日Jul 15, 2021
最高経営責任者「CEO」Mr. Robert (Rob) Spignesi
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+14.79%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+58.85%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
28.60K
+100.00%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Dr. Kirk D. Malloy, Ph.D.
Dr. Kirk D. Malloy, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. John Wilson
Mr. John Wilson
Chief Operating Officer
Chief Operating Officer
--
--
Mr. James Xu
Mr. James Xu
Senior Vice President - Legal, Company Secretary
Senior Vice President - Legal, Company Secretary
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+14.79%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+58.85%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
28.60K
+100.00%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Dr. Kirk D. Malloy, Ph.D.
Dr. Kirk D. Malloy, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Product revenue
4.10M
56.92%
Service revenue
3.10M
43.08%
地域別USD
会社名
収益
比率
United States
2.03M
28.12%
Switzerland
1.48M
20.54%
Germany
1.31M
18.17%
All other countries
1.27M
17.57%
Japan
1.12M
15.60%
事業別
地域別
事業別USD
会社名
収益
比率
Product revenue
4.10M
56.92%
Service revenue
3.10M
43.08%
株主
更新時刻: Fri, Aug 15
更新時刻: Fri, Aug 15
株主統計
種類
株主統計
株主統計
比率
Bain Capital Life Sciences Investors, LLC
21.24%
Kennedy Lewis Investment Management LLC
12.44%
Longitude Capital Management Co., LLC
8.96%
Endeavour Medtech Growth II LP
5.68%
Ally Bridge Group (HK) Limited
4.65%
他の
47.02%
株主統計
株主統計
比率
Bain Capital Life Sciences Investors, LLC
21.24%
Kennedy Lewis Investment Management LLC
12.44%
Longitude Capital Management Co., LLC
8.96%
Endeavour Medtech Growth II LP
5.68%
Ally Bridge Group (HK) Limited
4.65%
他の
47.02%
種類
株主統計
比率
Investment Advisor
36.76%
Venture Capital
9.06%
Investment Advisor/Hedge Fund
6.98%
Corporation
5.68%
Hedge Fund
5.25%
Individual Investor
4.21%
Private Equity
1.46%
Research Firm
0.04%
他の
30.56%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
68
28.04M
71.29%
+1.90M
2025Q1
76
27.59M
71.01%
+589.97K
2024Q4
81
24.48M
63.27%
-5.50M
2024Q3
105
26.74M
70.33%
-7.92M
2024Q2
116
27.58M
73.05%
-8.07M
2024Q1
141
28.00M
74.27%
-11.17M
2023Q4
153
28.87M
77.88%
-11.80M
2023Q3
163
30.20M
81.80%
-11.32M
2023Q2
163
30.56M
83.28%
-10.69M
2023Q1
166
31.93M
87.35%
-8.18M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Bain Capital Life Sciences Investors, LLC
8.43M
21.44%
--
--
Mar 31, 2025
Kennedy Lewis Investment Management LLC
4.94M
12.56%
--
--
Sep 30, 2024
Longitude Capital Management Co., LLC
3.56M
9.05%
--
--
Apr 07, 2025
Endeavour Medtech Growth II LP
2.26M
5.74%
--
--
Apr 07, 2025
Ally Bridge Group (HK) Limited
1.85M
4.7%
+810.00K
+78.01%
Mar 31, 2025
Schonfeld Strategic Advisors LLC
1.03M
2.62%
+1.03M
--
Mar 31, 2025
Parkman Healthcare Partners LLC
735.62K
1.87%
+735.62K
--
Mar 31, 2025
The Vanguard Group, Inc.
890.28K
2.26%
+169.15K
+23.46%
Mar 31, 2025
Advent International L.P.
577.78K
1.47%
--
--
Mar 31, 2025
Spignesi (Robert G JR)
872.37K
2.22%
+220.31K
+33.79%
Apr 07, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI